The presence of CD44+/CD24- tumor cells was not associated with ER and PgR status, with S-phase fraction or with tumor size, nor with lymph node status, menopausal status or age, although showing a tendency of being more common in premenopausal women. The gene discussed is CD24; the disease is neoplasm.